Brief Article
Copyright ©2012 Baishideng.
World J Hepatol. Sep 27, 2012; 4(9): 256-261
Published online Sep 27, 2012. doi: 10.4254/wjh.v4.i9.256
Table 2 Summary of follow-up in 320 untreated hepatocellular carcinoma patients (%)
OutcomePatients (n = 320)
Death292 (91)
Overall survival
Median (95% CI) (mo)6.8 (5.8-7.7)
1-yr survival rate32
2-yr survival rate13
BCLC A (early stage) survival
Median (95% CI) (mo)33 (20-46)
1-yr survival rate100
2-yr survival rate57
3-yr survival rate41
BCLC B (intermediate stage) survival
Median (95% CI) (mo)17.4 (14.8-20)
1-yr survival rate79
2-yr survival rate22
3-yr survival rate5
BCLC C (advanced stage) survival
Median (95% CI) (mo)6.9 (6.3-7.3)
1-yr survival rate12
BCLC D (end-stage) survival
Median (95% CI) (mo)1.8 (1.2-2.4)
1-yr survival rate0